![]() |
市场调查报告书
商品编码
1871942
全球虚拟实境治疗环境市场:预测至2032年-按治疗类型、交付方式、技术、应用、最终用户和地区进行分析Virtual-Reality Therapy Environments Market Forecasts to 2032 - Global Analysis By Therapy Type, Delivery Mode, Technology, Application, End User, and By Geography. |
||||||
根据 Stratistics MRC 的一项研究,预计到 2025 年,全球虚拟实境治疗环境市场价值将达到 11 亿美元,到 2032 年将达到 69 亿美元,预测期内复合年增长率为 29.9%。
虚拟实境治疗环境是由电脑生成的身临其境型环境,医疗专业人员利用这些环境为患者提供心理健康、復健和疼痛管理的治疗性介入。患者参与根据自身需求量身定制的受控互动场景中,从而进行暴露疗法、技能训练和认知训练。这些环境提供即时生物回馈疗法和数据分析,以改善治疗效果、提高患者参与度,并提升远距和临床环境下的医疗服务可近性。
根据美国心理学会的说法,VR暴露疗法为患者提供了一个可控、安全的环境,让他们能够面对和应对恐惧症和创伤后压力症候群,其有效性也得到了临床研究的支持。
在精神健康治疗中扩大应用
随着焦虑症、忧郁症和创伤后压力症候群(PTSD)的日益普遍,虚拟实境(VR)治疗环境正越来越多地融入心理健康治疗中。临床医生利用身临其境型模拟技术,在可控的数位环境中提供暴露疗法和压力缓解。与传统方法相比,这项技术提高了患者的治疗参与度和依从性。此外, VR头戴装置和生物回馈疗法技术的进步也正在改善治疗效果。因此,VR在精神医学领域的应用不断扩展,推动全球医疗保健系统的持续发展。
设备和安装高成本
儘管虚拟实境疗法展现出令人鼓舞的成果,但高昂的初始投资仍阻碍着其广泛应用。头戴式设备、动作感测器和计算系统的成本给小规模诊所和心理健康中心带来了沉重的财务负担。此外,软体客製化和治疗师培训的需求也增加了营运成本。开发中国家严格的报销政策进一步限制了其可近性。这些经济和后勤方面的障碍持续阻碍着虚拟实境疗法在整个医疗保健生态系统中的大规模应用。
扩大远距復健计划
在远端医疗革命的推动下,虚拟实境(VR)疗法融入远距復健体系,开启了无限可能。病患现在可以透过云端基础VR平台在家中接受指导性的认知和物理治疗。这种转变实现了持续监测和个人化自适应治疗。医疗服务提供者则受益于更高的扩充性和更低的营运成本。随着保险公司对远距復健的接受度不断提高,其在全球范围内向服务不足和偏远地区的扩展将成为推动成长的关键因素。
有限的临床检验和接受度
虚拟实境(VR)介入措施面临的主要挑战仍然是缺乏临床标准化和有限的长期疗效检验。许多项目缺乏大规模的、经同行评审的研究来证明其疗效的一致性。因此,医疗专业人员在开立身临其境型疗法处方时仍持谨慎态度。此外,患者对数位暴露疗法的怀疑态度也可能阻碍其广泛应用。如果没有更强有力的临床支持和监管协调,该行业的信誉在未来几年可能会受到严重限制。
疫情期间面对面治疗的限制极大地促进了人们对虚拟治疗平台的兴趣。心理健康机构更依赖虚拟实境(VR)程序来远端提供身临其境型认知行为疗法。疫情后的復苏工作进一步凸显了数位心理健康基础设施的重要性。此外,人们对心理健康意识提升也增强了VR长期应用的必要性。因此,新冠疫情已将VR疗法从一个实验性的小众领域转变为一种主流的治疗选择。
预计在预测期内,认知行为疗法细分市场将占据最大的市场份额。
预计在预测期内,认知行为疗法领域将占据最大的市场份额,这主要得益于虚拟实境技术在焦虑症、恐惧症和压力管理介入方面的广泛临床应用。身临其境型模拟能够增加患者接触可控压力源的机会,从而实现可衡量的进步并培养适应性应对机制。此外,治疗师还可以利用可自订的环境来有效应对个人化的触发因素。正在进行的研究表明,虚拟实境技术能够改善认知功能并降低復发率,这进一步巩固了该领域在虚拟实境治疗应用方面的领先地位。
预计在预测期内,远端/虚拟服务交付领域将实现最高的复合年增长率。
预计在预测期内,远端/虚拟治疗领域将实现最高成长率,这主要得益于云端基础治疗平台和家用VR设备的日益普及。此模式支援持续互动,并可实现即时进度追踪和治疗师监督。宽频普及率的提高和穿戴式装置的整合正在改善远距治疗体验。此外,疫情后远端医疗政策和灵活的报销政策正在加速患者接受远距治疗,从而推动该领域的快速扩张。
预计亚太地区将在预测期内占据最大的市场份额,这主要得益于医疗保健的快速数位化、心理健康意识宣传活动以及远距远端医疗基础设施的不断完善。日本、韩国和中国等国家已在精神病院和健康中心引入虚拟实境(VR)疗法。政府支持心理健康技术的倡议也进一步推动了其普及。可支配收入的成长和民众对技术的熟练正在推动身临其境型疗法解决方案在亚太地区的应用。
在预测期内,北美预计将实现最高的复合年增长率,这主要得益于强劲的技术创新、早期临床应用以及有利的法规结构。美国和加拿大在虚拟实境(VR)心理健康研究领域处于领先地位,这得益于大学临床试验和医疗保健Start-Ups的支持。与保险模式的整合以及人工智慧驱动的分析正在提高治疗的精确度。此外,数位医疗公司不断增加的投资也推动了全部区域市场的快速成长。
According to Stratistics MRC, the Global Virtual-Reality Therapy Environments Market is accounted for $1.1 billion in 2025 and is expected to reach $6.9 billion by 2032 growing at a CAGR of 29.9% during the forecast period. Virtual-Reality Therapy Environments are immersive, computer-generated settings used by healthcare professionals to deliver therapeutic interventions for mental health, rehabilitation, or pain management. Patients engage in controlled, interactive scenarios tailored to their needs, enabling exposure therapy, skills training, and cognitive exercises. The environments provide real-time biofeedback and data analytics, enhancing therapy efficacy, patient engagement, and access to care in remote or clinical contexts.
According to the American Psychological Association, VR exposure therapy is providing controlled, safe environments for patients to confront and manage phobias and PTSD, with efficacy supported by clinical studies.
Growing use in mental health treatment
Propelled by the rising prevalence of anxiety, depression, and PTSD, virtual reality (VR) therapy environments are increasingly integrated into mental health treatment. Clinicians are adopting immersive simulations to deliver exposure therapy and stress reduction in controlled digital settings. This technology enhances engagement and treatment adherence compared to traditional methods. Moreover, advancements in VR headsets and biofeedback integration improve therapeutic outcomes. Consequently, expanding psychiatric applications are fueling sustained growth across global healthcare systems.
High equipment and setup cost
Despite promising results, the widespread adoption of VR therapy is hindered by high initial investment requirements. The cost of headsets, motion sensors, and computing systems poses financial challenges for small clinics and mental health centers. Additionally, the need for software customization and therapist training adds to operational expenses. Limited reimbursement policies further restrict affordability in developing economies. These financial and logistical barriers continue to slow mass deployment across healthcare ecosystems.
Expansion in remote rehabilitation programs
Spurred by the telehealth revolution, VR therapy's integration into remote rehabilitation frameworks offers immense potential. Patients can now access guided cognitive or physical therapy sessions from home through cloud-based VR platforms. This shift enables continuous monitoring and adaptive treatment personalization. Healthcare providers benefit from improved scalability and reduced overheads. As insurers increasingly recognize tele-rehabilitation, global expansion into underserved and rural populations becomes a key growth catalyst.
Limited clinical validation and acceptance
A major challenge lies in the limited clinical standardization and long-term efficacy validation of VR-based interventions. Many programs lack large-scale, peer-reviewed studies demonstrating consistent outcomes. Consequently, medical professionals remain cautious about prescribing immersive therapies. Moreover, skepticism among patients regarding digital exposure treatments may hinder adoption. Without stronger clinical backing and regulatory alignment, industry credibility could face significant constraints over the coming years.
The pandemic dramatically accelerated interest in virtual therapy platforms due to restricted in-person sessions. Mental health facilities increasingly relied on VR programs to deliver immersive cognitive and behavioral therapies remotely. Post-pandemic recovery initiatives further emphasized digital mental healthcare infrastructure. Moreover, increased awareness of psychological well-being strengthened the case for long-term VR adoption. Thus, COVID-19 transformed VR therapy from an experimental niche to a mainstream therapeutic alternative.
The cognitive behavioral therapy segment is expected to be the largest during the forecast period
The cognitive behavioral therapy segment is expected to account for the largest market share during the forecast period, resulting from widespread clinical adoption of VR for anxiety, phobia, and stress management interventions. Immersive simulations enhance patient exposure to controlled stressors, enabling measurable progress and adaptive coping mechanisms. Moreover, therapists leverage customizable environments to address individual triggers effectively. Continued research demonstrating cognitive improvement and reduced relapse rates further consolidates this segment's dominance in therapeutic VR applications.
The remote/virtual delivery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the remote/virtual delivery segment is predicted to witness the highest growth rate, propelled by the growing availability of cloud-based therapeutic platforms and at-home VR devices. This model supports continuous engagement, allowing real-time progress tracking and therapist supervision. Increasing broadband penetration and wearable integration enhance the remote therapy experience. Furthermore, post-pandemic telehealth policies and reimbursement flexibility are accelerating patient adoption, fueling exponential segment expansion.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, attributed to rapid healthcare digitization, mental health awareness campaigns, and expanding telemedicine infrastructure. Countries like Japan, South Korea, and China are integrating VR therapy within psychiatric hospitals and wellness centers. Government initiatives supporting mental wellness technologies further bolster adoption. Rising disposable incomes and tech-savvy populations enhance regional uptake of immersive therapeutic solutions.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR associated with strong technological innovation, early clinical adoption, and supportive regulatory frameworks. The U.S. and Canada lead in VR mental health research, supported by university trials and healthcare startups. Integration with insurance models and AI-driven analytics amplifies treatment precision. Additionally, increasing investment from digital health companies reinforces rapid market growth across the region.
Key players in the market
Some of the key players in Virtual-Reality Therapy Environments Market include XRHealth, Psious, Oxford VR, AppliedVR, Limbix, BehaVR, MindMaze, Pear Therapeutics, Virtually Better, Firsthand Technology, Emersa Health, Karuna Labs, Samsung, HP, Meta, and Google.
In October 2025, AppliedVR launched an upgraded version of its "EaseVRx" platform, improving the fidelity and personalization of its immersive pain distraction environments. The update now uses real-time biometric feedback (via integrated wearables) to dynamically adjust scene complexity and narrative pacing, enhancing non-pharmacological pain management for chronic conditions.
In September 2025, Oxford VR expanded its evidence-based "gameChange" therapy platform to the US market, now supporting a wider range of social anxiety and agoraphobia scenarios. The update includes AI-driven coaching avatars that provide personalized cognitive interventions within the VR environment, tailored to the user's in-session anxiety levels.
In August 2025, XRHealth & Meta announced a strategic partnership to deploy specialized therapeutic VR environments on the Meta Quest Pro platform for clinical and at-home use. The collaboration integrates XRHealth's clinical software with Meta's advanced eye and face tracking to better monitor patient engagement and emotional response during therapy sessions.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.